MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,900,939 | -35.3% | 19,864 | +2.3% | 0.02% | -26.1% |
| Q2 2023 | $4,483,248 | -11.3% | 19,408 | -7.0% | 0.02% | -14.8% |
| Q1 2023 | $5,054,997 | +8.0% | 20,866 | +29.4% | 0.03% | +8.0% |
| Q4 2022 | $4,678,830 | +305.8% | 16,120 | +46.5% | 0.02% | +525.0% |
| Q2 2019 | $1,153,000 | -49.8% | 11,000 | -40.0% | 0.00% | -55.6% |
| Q1 2019 | $2,296,000 | +10.0% | 18,333 | -1.1% | 0.01% | -10.0% |
| Q4 2018 | $2,088,000 | -23.5% | 18,528 | +45.4% | 0.01% | 0.0% |
| Q3 2018 | $2,729,000 | -35.1% | 12,746 | -15.2% | 0.01% | -44.4% |
| Q2 2018 | $4,203,000 | +299.9% | 15,028 | +67.0% | 0.02% | +260.0% |
| Q1 2018 | $1,051,000 | +90.7% | 9,000 | +50.0% | 0.01% | +150.0% |
| Q4 2017 | $551,000 | – | 6,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Avoro Capital Advisors LLC | 463,000 | $99,142,000 | 4.55% |
| Rock Springs Capital Management LP | 342,000 | $73,232,000 | 2.65% |
| ACUTA CAPITAL PARTNERS, LLC | 33,000 | $7,066,000 | 2.52% |
| HealthCor Management, L.P. | 262,860 | $56,286,000 | 1.87% |
| Baker Brothers Advisors | 1,169,278 | $250,377,000 | 1.65% |
| EMORY UNIVERSITY | 11,391 | $2,439,000 | 1.60% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 8,690 | $1,862,000 | 1.48% |
| GREAT POINT PARTNERS LLC | 40,400 | $8,651,000 | 1.35% |
| SHIKIAR ASSET MANAGEMENT INC | 15,341 | $3,285,000 | 1.28% |
| ARMISTICE CAPITAL, LLC | 80,000 | $17,130,000 | 1.03% |